Question 1

What specific symptoms of my schizophrenia could this treatment help with?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Navigated αTMS in Treatment-resistant Schizophrenia clinical trial (NCT01941251). Contact the study team or your healthcare provider for specific answers.

Question 2

How does αTMS compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Navigated αTMS in Treatment-resistant Schizophrenia clinical trial (NCT01941251). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects or risks associated with this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Navigated αTMS in Treatment-resistant Schizophrenia clinical trial (NCT01941251). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during and after the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Navigated αTMS in Treatment-resistant Schizophrenia clinical trial (NCT01941251). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience any adverse effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Navigated αTMS in Treatment-resistant Schizophrenia clinical trial (NCT01941251). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Navigated αTMS in Treatment-resistant Schizophrenia clinical trial (NCT01941251). Contact the study team or your healthcare provider for specific answers.

What this study is about